CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-19 | Kulkarni Samarth Chief Executive Officer | Option exercise | +4,307 | $1.81 | $8K | 175,833 |
| 2020-05-19 | Kulkarni Samarth Chief Executive Officer | Sale | −4,307 | $65.16 | $281K | 171,526 |
| 2020-05-19 | Kulkarni Samarth Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −4,307 | 190,751 | ||
| 2020-05-11 | Klein Lawrence Otto CBO & COO | Option exercise | +25,000 | $5.86 | $147K | 45,000 |
| 2020-05-11 | Klein Lawrence Otto CBO & COO | Sale | −24,318 | $60.38 | $1.5M | 20,682 |
| 2020-05-11 | Klein Lawrence Otto CBO & COO | Sale | −682 | $61.07 | $42K | 20,000 |
| 2020-05-11 | Klein Lawrence Otto CBO & COO | Option exercise · Stock Option (Right to Buy) | −25,000 | 38,666 | ||
| 2020-03-10 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-03-10 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2020-03-10 | Kulkarni Samarth Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +142,000 | 142,000 | ||
| 2020-03-10 | Kulkarni Samarth Chief Executive Officer | Grant or award · Restricted Stock Units | +35,500 | 35,500 | ||
| 2020-03-10 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-03-10 | KASINGER JAMES R. General Counsel and Secretary | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2020-03-10 | Ho Tony W Executive VP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-03-10 | Ho Tony W Executive VP, Head of R&D | Grant or award · Restricted Stock Units | +13,750 | 13,750 | ||
| 2020-03-10 | Klein Lawrence Otto CBO & COO | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2020-03-10 | Klein Lawrence Otto CBO & COO | Grant or award · Restricted Stock Units | +13,750 | 13,750 | ||
| 2020-03-06 | Ho Tony W Executive VP, Head of R&D | Shares withheld for taxes | −1,563 | $52.64 | $82K | 47,605 |
| 2020-03-05 | Ho Tony W Executive VP, Head of R&D | Option exercise | +3,333 | 49,168 | ||
| 2020-03-02 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −794 | $52.74 | $42K | 171,526 |
Page 44 of 46 · 910 trades